RUNX1 and acute myeloid leukemia: RT-qPCR assays are available for MRD detection of specific genetic lesions found in sub-groups of patients with AML, including NPM1 mutations, CBFB-MYH11, RUNX1-RUNX1T1, and BCR-ABL1 fusion genes.